DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @StockNewsNow | 2 |
| @bbnsnews | 2 |
| @HottestStockNow | 2 |
| @BrainstormCell | 2 |
| @zackcapp | 1 |
Recent Tweets for BCLI
 |
@ZacksSmallCap $BCLI: @BrainstormCell Closing in on Full Enrollment for Phase 3 ALS Trial - https://t.co/tved00Biwd by @DavidBautz https://t.co/lucNgEqoOQ May 21st 2019, 10:05am |
 |
@bbnsnews Maxim Group Reiterates Buy Rating for Brainstorm Cell Therapeutics $BCLI https://t.co/586a0G5Jht May 18th 2019, 7:05am |
 |
@ThisLincolnian Maxim Group Reiterates Buy Rating for Brainstorm Cell Therapeutics $BCLI https://t.co/ZBxGW5VlJx May 18th 2019, 7:05am |
 |
@bulletin_en Comparing of ContraVir Pharmaceuticals Inc. $BCLI https://t.co/GvUVguRCAg May 18th 2019, 7:05am |
 |
@AnalystsAnalyst $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/VyyCFBwZFw $BCLI @BrainstormCell #biotech… https://t.co/6KI6orL7Km May 16th 2019, 3:05pm |
 |
@listbuys RT @FinZTribune: Brainstorm Cell Therapeutics $BCLI Holder Sabby Management Upped Position; Amazon Com $AMZN Holder New England Private Wea… May 16th 2019, 2:05pm |
 |
@FinZTribune Brainstorm Cell Therapeutics $BCLI Holder Sabby Management Upped Position; Amazon Com $AMZN Holder New England Priv… https://t.co/JmZSTS2mIJ May 16th 2019, 2:05pm |
 |
@Cylebo RT @DavidBautz: $BCLI with a new video that gives a good overview of NurOwn: https://t.co/tN80GaCJ54 May 16th 2019, 1:05pm |
 |
@BioPharmaJess RT @BrainstormCell: $BCLI CEO Chaim Lebovits is participating now in a panel of global leaders in #celltherapy at 2:35pm at #WATRMC19. Topi… May 16th 2019, 12:05pm |
 |
@SeekingAlpha $BCLI - Brainstorm Cell Therapeutics: Poor Cash And Specific Risks Make This An Avoid https://t.co/exeYtkI2xF May 16th 2019, 11:05am |
 |
@BrainstormCell $BCLI CEO Chaim Lebovits is participating now in a panel of global leaders in #celltherapy at 2:35pm at #WATRMC19.… https://t.co/kIb43gOPBP May 16th 2019, 9:05am |
 |
@DavidBautz $BCLI treated 3 #ALS patients in Israel under hospital exemption program and received $1M total for those three pat… https://t.co/rpoVCJRHZr May 16th 2019, 8:05am |
 |
@WATRMC RT @BrainstormCell: $BCLI is here at #WATRMC19 in London. CEO Chaim Lebovits is speaking on 2 panels today at 12:10pm (Table 4. Stem Cells… May 16th 2019, 8:05am |
|
@BrainstormCell $BCLI is here at #WATRMC19 in London. CEO Chaim Lebovits is speaking on 2 panels today at 12:10pm (Table 4. Stem Ce… https://t.co/j7uB4ewED9 May 16th 2019, 7:05am |
|
@dakotafinancial Brainstorm Cell Therapeutics’ $BCLI Buy Rating Reaffirmed at Maxim Group https://t.co/Njw31Wtnwg May 16th 2019, 6:05am |
 |
@AmericanBanking Brainstorm Cell Therapeutics $BCLI Rating Reiterated by Maxim Group https://t.co/FxWr6ORVQA #stocks May 14th 2019, 2:05pm |
 |
@TheMarketsDaily Brainstorm Cell Therapeutics $BCLI Receives “Buy” Rating from Maxim Group https://t.co/kbIDtGIRiE May 14th 2019, 2:05pm |
 |
@ahighelevation $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/aopLwI71qF $BCLI @BrainstormCell #biotech… https://t.co/rlHQpmyjHO May 14th 2019, 12:05am |
 |
@ContentCarnivor $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/pIk9b7CYEA $BCLI @BrainstormCell #biotech… https://t.co/mK42dODIWo May 13th 2019, 8:05pm |
 |
@tzack16 $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/4KhOqGowQ4 $BCLI @BrainstormCell #biotech… https://t.co/8J5FVU1Ccl May 13th 2019, 7:05pm |
 |
@risk_averse_ $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/ryZkiZ2bpX $BCLI @BrainstormCell #biotech… https://t.co/OncOktyjLD May 13th 2019, 5:05pm |
 |
@ZacksAwareness $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/S1wgML1qpw $BCLI @BrainstormCell #biotech… https://t.co/AyZOAXhocJ May 13th 2019, 4:05pm |
 |
@InstitutionalZC $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/B2CCCwROUx $BCLI @BrainstormCell #biotech… https://t.co/jEizNDQwHb May 13th 2019, 4:05pm |
 |
@zackcappsocial $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/S9t60EauOG $BCLI @BrainstormCell #biotech… https://t.co/QYPDc4W6Pk May 13th 2019, 3:05pm |
 |
@TheTruthStudio $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/j71MzoCBfw $BCLI @BrainstormCell #biotech… https://t.co/FliykNceXw May 13th 2019, 3:05pm |
 |
@zackcapp $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/bWZe2k1ExC $BCLI @BrainstormCell #biotech… https://t.co/Ms0j8ApRZQ May 13th 2019, 3:05pm |
 |
@HowieRegay $BCLI Phase 2 Trial of Stem Cell Treatment for MS Underway https://t.co/CFvGsQqlu5 $BCLI @BrainstormCell #biotech… https://t.co/RZfq1VJvgt May 13th 2019, 1:05pm |
 |
@StockNewsNow $BCLI BrainStorm CEO to Present at the World Advanced Therapy and Regenerative Medicine Congress in London https://t.co/hqvhK1Iti0 May 13th 2019, 11:05am |
 |
@StockTexts $BCLI Brainstorm Cell Therapeutics Inc. SEC Filing: Form 8-K https://t.co/8UzMWfsZM2 May 13th 2019, 8:05am |
 |
@HottestStockNow $BCLI to provide an update on its two clinical trials of NurOwn https://t.co/SmA6sXDGiR May 13th 2019, 5:05am |
|
@HottestStockNow $BCLI 's Numbers Revealed https://t.co/SmA6sXDGiR May 11th 2019, 9:05pm |
|
@bbnsnews Zacks: Brainstorm Cell Therapeutics Inc $BCLI Given Average Recommendation of “Strong Buy” by Brokerages https://t.co/JAwfZZatXl May 11th 2019, 11:05am |
|
@StockNewsNow $BCLI BrainStorm Announces Financial Results for the First Quarter of 2019 and Provides a Corporate Update https://t.co/P3ChoiMDSQ May 10th 2019, 5:05pm |
 |
@Stock_News_Now $BCLI: New SEC Filing for BCLI: Form 10-Q (No. 0001144204-19-025310): https://t.co/5AfL7wBgfS May 10th 2019, 5:05pm |
 |
@MarketCurrents $BCLI - BrainStorm Cell Therapeutics misses by $0.13 https://t.co/tmBh5a6UoQ May 10th 2019, 5:05pm |
|
@FinZTribune Aileron Therapeutics Inc. $BCLI Comparing side by side https://t.co/HFK9eEWMmg May 9th 2019, 11:05pm |
 |
@MariCred RT @BrainstormCell: $BCLI: At #AANAM today, visit our POSTER P5.2-081 in IMMUNOTHERAPIES session to learn more about the potential role of… May 9th 2019, 11:05pm |
|
@BrainstormCell $BCLI: At #AANAM today, visit our POSTER P5.2-081 in IMMUNOTHERAPIES session to learn more about the potential role… https://t.co/TBGY3NoBrk May 9th 2019, 11:05am |
 |
@WeekHerald Zacks: Brainstorm Cell Therapeutics Inc $BCLI Given $12.25 Consensus Target Price by Brokerages https://t.co/Cl9VOTZiQk May 9th 2019, 9:05am |
|
@DavidBautz $BCLI with a new video that gives a good overview of NurOwn: https://t.co/tN80GaCJ54 May 8th 2019, 8:05am |
 |
@MedChem_DGBrown RT @BrainstormCell: $BCLI: At #AANAM, Dr. Ralph Kern is presenting Abstract 011 on the potential role of Caspase-3 in #ALS in EMERGING SCIE… May 7th 2019, 10:05pm |
|
@BrainstormCell $BCLI: At #AANAM, Dr. Ralph Kern is presenting Abstract 011 on the potential role of Caspase-3 in #ALS in EMERGING… https://t.co/uVHPkIqfO1 May 7th 2019, 12:05pm |
 |
@TranscriptDaily Brokerages Set $12.25 Target Price for Brainstorm Cell Therapeutics Inc $BCLI https://t.co/CD92yS1P4j May 6th 2019, 2:05pm |
|
@AmericanBanking Brainstorm Cell Therapeutics Inc $BCLI Given $12.25 Consensus Target Price by Brokerages https://t.co/qhT91hV30Y #stocks May 6th 2019, 2:05pm |
 |
@SwingTradeBot Rose Above 50 DMA today: $BCLI $SDOW ... https://t.co/qwiJH6vr1O May 6th 2019, 9:05am |
|
@AnalystsAnalyst $BCLI New Data for ALS Stem Cell Therapy at AAN https://t.co/HABNpHLoqu $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/3KVzGNfA5s May 5th 2019, 3:05pm |
|
@ContentCarnivor $BCLI New Data for ALS Stem Cell Therapy at AAN https://t.co/JKSYXhyRUu $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/LxTMBqdSr8 May 2nd 2019, 4:05pm |
|
@ahighelevation $BCLI New Data for ALS Stem Cell Therapy at AAN https://t.co/EHuE8v716T $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/bEuEVTntFV May 2nd 2019, 8:05am |
|
@risk_averse_ $BCLI New Data for ALS Stem Cell Therapy at AAN https://t.co/ZsddgvzkCa $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/4noyMqAUeW May 1st 2019, 6:05pm |
|
@ZacksAwareness $BCLI New Data for ALS Stem Cell Therapy at AAN https://t.co/6vohaKxeRx $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/kqxocXt7qX May 1st 2019, 4:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.